Arbutus Biopharma (ABUS) Preferred Dividend Payments (2017 - 2021)

Arbutus Biopharma (ABUS) has reported Preferred Dividend Payments for 5 consecutive years, with $574000.0 the latest figure, recorded in Q4 2021.

• Quarterly Preferred Dividend Payments fell 81.62% year-over-year to $574000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $574000.0 (down 96.09% YoY) and the FY2021 annual result came in at $12.1 million, changed 0.13% from the prior year.
• Preferred Dividend Payments fell to $574000.0 in Q4 2021 per ABUS's latest filing, from $5.1 million in the prior quarter.
• Over the last five years, Preferred Dividend Payments for ABUS reached as high as $5.1 million in Q3 2021 and fell as low as $574000.0 in Q4 2021.
• A 5-year average of $2.7 million and a median of $2.8 million in 2019 frame the typical range for Preferred Dividend Payments.
• Annual changes were most pronounced in 2018 — Preferred Dividend Payments surged 190.56% — and 2021, when it tumbled 81.62%.
• Year by year, Preferred Dividend Payments stood at $911000.0 in 2017, then surged by 190.56% to $2.6 million in 2018, then advanced by 8.8% to $2.9 million in 2019, then grew by 8.44% to $3.1 million in 2020, then sank by 81.62% to $574000.0 in 2021.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered $574000.0, $5.1 million, and $3.3 million for Q4 2021, Q3 2021, and Q2 2021 respectively.